Covance
Contact Us   |  Client Login  

  • PRODUCTS & SERVICES
    • Antibody Products
      • Antibody Products Store
      • Neuroscience
      • Epitope Tags
      • Structural Proteins & Cell Components
      • Signal Transduction
      • Immunopathology
      • Detection Chemistries & Ancillaries
      • Custom Immunology Services
    • Clinical Services
      • Bioanalytical
      • Central Laboratory
      • Clinical Development (Phase I-III)
    • Discovery & Translational Services
      • Antibody Products
      • Biomarker Center of Excellence
      • BioPathways
      • Computational Biology
      • Genomics Laboratory
      • Immunology
      • Lead Optimization
      • Vaccines & Infectious Disease
    • Nonclinical Services
      • Antibody Products
      • Bioanalytical Services
      • Drug Metabolism & Pharmacokinetics
      • Immunology
      • Lead Optimization
      • Radiosynthesis
      • Research Models
      • Safety Pharmacology
      • Toxicology
      • Vaccines & Infectious Disease
    • Biopharmaceutical CMC Solutions
    • Biorepository Services
    • Environmental Sciences
    • Genomics Laboratory
    • Integration in Drug Development
    • Market Access
    • Nutritional Chemistry & Food Safety
    • Secure Data Access
    • Strategic Partnering

  • CAREERS
    • Search Jobs
    • College / University
    • Featured Jobs
    • Diversity
    • Benefits
    • 现在就加入科文斯

  • STUDY PARTICIPANTS

  • INVESTORS
    • Investor Information
      • Investor Home
      • Stock Information
      • Board of Directors
      • Corporate Governance Guidelines
      • Analyst Coverage
      • Investor FAQ
      • Presentations & Webcasts
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Press Releases
    • Calendar of Events
    • Request Information

  • NEWS
    • Press Releases
    • Media Relations

  • ABOUT COVANCE
    • Company Overview
    • Industry Overview
    • History of Covance
    • Mission & Vision
    • Global Locations
    • Executive Leadership
    • Events
    • Corporate Responsibility
    • Supplier Code of Conduct
    • Business Integrity Program
    • Animal Welfare
    • Covance.Asia

  • RESOURCE CENTER
    • Blog
   
 
 
   
Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its lead optimization, nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.
Biosimilars Development
Address Key Considerations
and Unique Challenges

Article and webinar available
  Xcellerate®
Shorten the Road to Successful Clinical Trials
Learn how
Annual Meeting Documents
View Our 2012 Annual Report and 2013 Proxy Statement
13 May 2013
Covance To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
1 May 2013
Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
16 April 2013
Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients' Increased Asia Pacific Focus
News: Read More   |   Events: Read More
Home | Animal Welfare | Privacy Policy | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2013 Covance Inc. All rights reserved.